Aim: Pneumonia is a major cause of death in patients with schizophrenia. Preventive strategies based on identifying the risk factors are needed to reduce pneumonia-related mortality. This study aimed to clarify the risk factors for pneumonia in patients with schizophrenia.
proper health care, (b) less access to physical healthcare resources, and (c) increased risk of complications. 4, 5 One of the major causes of death in patients with schizophrenia is pneumonia. 6 Pneumonia accounts for about half of all deaths in psychiatric hospitals 7, 8 and has a higher incidence among patients with schizophrenia than the general population. Patients with schizophrenia had a higher incidence of pneumonia (odds ratio = 1.77) in Taiwan. 9 The risk of pneumococcal disease in patients with schizophrenia was also high in England (odds ratio = 2.3). 10 Preventive strategies based on modifiable risk factors are important to reduce pneumonia-related mortality.
The risk factors for pneumonia in the general population have been well-studied. Koviula et al. reported that advanced age, alcoholism, and comorbidities were independent risk factors for pneumonia. 11 Farr et al 12 added the importance of cigarette smoking.
Almirall et al 13 found that underweight and previous pneumonia history were significant risk factors. However, to the best of our knowledge, no studies have examined the risk factors for pneumonia among patients with schizophrenia.
Although our hospital is a psychiatric hospital, we have a Medical Comorbidity Ward and have treated patients with both schizophrenia and pneumonia. 14 We therefore performed a retrospective cohort study to elucidate the risk factors for pneumonia in patients with schizophrenia.
| ME TH ODS

| Study population
The clinical files of consecutive patients with schizophrenia who were admitted to Tokyo Metropolitan Matsuzawa Hospital during a four-year period from January 2014 to December 2017 were retrospectively reviewed. If patients were admitted more than once during the study period, the data from their first hospitalization were used. Patients whose period of hospitalization was no more than a couple of days were excluded because their diagnosis of schizophrenia was deemed to be less reliable, and the clinical information regarding the patient was also deemed to be inadequate. The diagnosis of schizophrenia was made by psychiatric physicians in accordance with the ICD-10 criteria. 15 This study was approved by the institutional review board of Tokyo Metropolitan Matsuzawa Hospital, and written informed consent was waived because of the retrospective design. Patient anonymity was preserved.
We examined each patient's physical characteristics and clinical parameters on admission. The database developed here included the type and dose of the prescribed antipsychotics. For the latter, we used the chlorpromazine equivalent dose table developed by Toru, which is the most commonly used conversion chart in Japan. 16 In addition, the physical characteristics and clinical parameters were compared between the two patient groups with and without pneumonia on admission in order to detect the risk factors for pneumonia. At Tokyo Metropolitan
Matsuzawa Hospital, all patients are asked to undergo a chest X-ray on admission. Internal medicine physicians diagnosed pneumonia based on clinical symptoms suggestive of pneumonia (cough, fever, productive sputum, dyspnea, chest pain, or abnormal breath sounds), and pneumonic infiltration detected by chest X-ray. A multivariate analysis determined which risk factors were related to pneumonia.
| Statistical analyses
Quantitative data are presented as the mean ± standard deviation. 
| RESULTS
A clinical chart of 4253 admissions and 2974 patients with schizophrenia during the study period was reviewed. Of the 2974 patients, 2209 patients were included in this study ( Figure 1 ).
The characteristics of the patients are summarized in Table 1 . The prescribed antipsychotics differed significantly between the patients with and without pneumonia ( Table 1) . Typical antipsychotics were prescribed less frequently and atypical antipsychotics were prescribed more frequently to patients with pneumonia than to those without pneumonia. The total chlorpromazine equivalent dose was significantly higher for the patients with pneumonia than for those without pneumonia (692.0 ± 336.0 vs 517.5 ± 269.2 mg, P < 0.001). Figure 2 shows the distribution of the patients according to the total chlorpromazine equivalent dose. The proportion of patients with pneumonia is shown in Figure 3 . The increased risk of pneumonia was dose-dependently observed.
To identify the risk factors related to pneumonia, we performed multivariate analysis ( Table 2 ). Use of atypical antipsychotics had the highest odds ratio among the predictive factors (2.7; 95% confidence interval [CI] 1.0-17.7; P = 0.046), followed by large dose of antipsychotics (2.6; 95% CI 1.7-4.0; P < 0.001), underweight (2.3; 95% CI 1.6-3.6; P < 0.001), smoking history (2.0; 95% CI 1.3-3.1; P < 0.001), and advanced age (1.7; 95% CI 1.2-2.6; P = 0.01).
| DISCUSSION
We identified significant risk factors for pneumonia in patients with schizophrenia, which were advanced age, underweight, smoking habit, and administration of a higher chlorpromazine equivalent dose or atypical antipsychotics. While this study corroborates the findings of previous studies on the risk factors for pneumonia in the general population, it also provides more established evidence of factors associated with the occurrence of pneumonia in patients with schizophrenia.
This knowledge will provide the means of identifying groups that are at risk for pneumonia and require preventive intervention.
Advanced age seems to be related to the development of pneumonia. This may be the result of a general weakening of the immune system, efficacy of vaccines, mucosal barrier function, and cough reflex. 17, 18 Our study revealed that advanced age was an independent risk factor for pneumonia. Aged patients with schizophrenia in particular should be carefully observed for the development of pneumonia.
Nutrition has a close relationship with susceptibility to infection.
Malnutrition by itself increases the host's susceptibility to infectious diseases, and these infections, in turn, have negative repercussions on the metabolism of the host, worsening the host's nutritional state. 19 BMI is widely used as an index of an individual's nutritional status. 20 Several studies have revealed that underweight is associated with the risk of pneumonia. 13, 21 Underweight is prevalent in Japanese patients with schizophrenia. Sugai et al 22 reported that Japanese patients with schizophrenia showed a higher prevalence of underweight than the general Japanese population (13.8% vs 7.9%).
In the present study, the prevalence of underweight in patients with schizophrenia was consistent with the findings of previous studies (patients with pneumonia: 41.6%; patients without pneumonia: 23%).
Because underweight is a potentially treatable condition, nutritional intervention for underweight patients with schizophrenia deserves serious consideration. control study. 23 Smoking is highly prevalent among patients with schizophrenia, but these patients are less likely to be treated than patients without schizophrenia. 24 Despite the concern that smoking cessation may exacerbate psychiatric symptoms in patients with schizophrenia, the current evidence does not support this assumption. 25 Smoking cessation should be taken into account as a means of preventing pneumonia in patients with schizophrenia.
The use of antipsychotics has been suggested as a possible risk factor for pneumonia. Several observational studies were conducted to explore the association between the use of antipsychotics and pneumonia in a cohort of elderly patients with dementia. 26 Blocking dopamine receptors may result in an extrapyramidal effect (dyskinesia, rigidity, and spasm of the oral and pharyngeal muscles), which can result in dysphagia and ultimately in aspiration pneumonia. 27 In the present study, the chlorpromazine equivalent dose for antipsychotics was associated with an increase in the risk of pneumonia.
Interestingly, the use of typical antipsychotics was not associated with the development of pneumonia whereas the use of atypical The blockade of H1 receptors may lead to excessive sedation, which can result in a decreased swallowing reflex and thereby conduce to pneumonia. 29 For patients with a high risk of pneumonia, physicians should make an effort to reduce the dose of antipsychotics, especially atypical antipsychotics, if the patient's psychotic symptoms can be controlled.
The present study has several limitations. First, we were unable to evaluate the severity of psychiatric conditions on admission due to the retrospective study design. The severity of schizophrenia itself might affect the patient's ability to swallow, which can in turn affect the development of pneumonia. 30 In addition, overdose of benzodiazepines, catatonic stupor, and bedridden status is reportedly risk factors for pneumonia. 31 Further study is needed to determine whether the severity of schizophrenia itself and the use of psychoactive drugs other than antipsychotics are also risk factors for pneumonia. Second, our study demonstrated an association between the use of atypical antipsychotics and pneumonia. However, we were unable to determine how and why atypical antipsychotics were used before the patients were admitted to Tokyo Metropolitan Matsuzawa Hospital. Thus, whether the use of atypical antipsychotics was a direct cause of pneumonia is uncertain. Third, in our study, 765
patients who moved to another hospital after a few days were not included, possibly influencing our findings. Finally, because this was a retrospective cohort study, a prospective study is needed to validate our results.
In conclusion, we demonstrated that advanced age, underweight, smoking habit, use of atypical antipsychotics, and large doses of antipsychotics were risk factors for pneumonia in patients with schizophrenia. Further study based on our results is needed to establish preventive strategies to reduce pneumonia-related death among schizophrenic patients with pneumonia.
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